{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:03:39Z","timestamp":1793754219526,"version":"4.6.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171750"],"award-info":[{"award-number":["82171750"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82150104"],"award-info":[{"award-number":["82150104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203938"],"award-info":[{"award-number":["82203938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071850"],"award-info":[{"award-number":["82071850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030095"],"award-info":[{"award-number":["82030095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232095"],"award-info":[{"award-number":["7232095"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-025-01325-3","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T01:26:56Z","timestamp":1755134816000},"page":"1109-1122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The cytokine CSBF inhibits the IL-17A and TNF-\u03b1 inflammatory pathways via SUSD2-ACT1 in keratinocytes and alleviates IMQ-induced psoriasis"],"prefix":"10.1038","volume":"22","author":[{"given":"Xixi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-8683","authenticated-orcid":false,"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"1325_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama. 2020;323:1945\u201360.","journal-title":"Jama"},{"key":"1325_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"1325_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41590-022-01339-3","volume":"23","author":"X Ni","year":"2022","unstructured":"Ni X, Xu Y, Wang W, Kong B, Ouyang J, Chen J, et al. IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation. Nat Immunol. 2022;23:1577\u201387.","journal-title":"Nat Immunol"},{"key":"1325_CR4","doi-asserted-by":"publisher","first-page":"eabi4425","DOI":"10.1126\/sciimmunol.abi4425","volume":"6","author":"Z Kurgyis","year":"2021","unstructured":"Kurgyis Z, Vornholz L, Pechloff K, Kem\u00e9ny LV, Wartewig T, Muschaweckh A, et al. Keratinocyte-intrinsic BCL10\/MALT1 activity initiates and amplifies psoriasiform skin inflammation. Sci Immunol. 2021;6:eabi4425.","journal-title":"Sci Immunol"},{"key":"1325_CR5","doi-asserted-by":"publisher","first-page":"eabi8823","DOI":"10.1126\/sciimmunol.abi8823","volume":"6","author":"RK Gupta","year":"2021","unstructured":"Gupta RK, Gracias DT, Figueroa DS, Miki H, Miller J, Fung K, et al. TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy. Sci Immunol. 2021;6:eabi8823.","journal-title":"Sci Immunol"},{"key":"1325_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8:437.","journal-title":"Signal Transduct Target Ther"},{"key":"1325_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397:754\u201366.","journal-title":"Lancet"},{"key":"1325_CR8","doi-asserted-by":"publisher","first-page":"100266","DOI":"10.1016\/j.lanepe.2021.100266","volume":"13","author":"L Davidson","year":"2022","unstructured":"Davidson L, van den Reek J, Bruno M, van Hunsel F, Herings R, Matzaraki V, et al. Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources. Lancet Reg Health Eur. 2022;13:100266.","journal-title":"Lancet Reg Health Eur"},{"key":"1325_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.immuni.2020.06.004","volume":"53","author":"F Lou","year":"2020","unstructured":"Lou F, Sun Y, Xu Z, Niu L, Wang Z, Deng S, et al. Excessive polyamine generation in keratinocytes promotes self-RNA sensing by dendritic cells in psoriasis. Immunity. 2020;53:204\u201316.e10.","journal-title":"Immunity"},{"key":"1325_CR10","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.immuni.2023.04.001","volume":"56","author":"R Bharadwaj","year":"2023","unstructured":"Bharadwaj R, Lusi CF, Mashayekh S, Nagar A, Subbarao M, Kane GI, et al. Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity. Immunity. 2023;56:998\u20131012.e8.","journal-title":"Immunity"},{"key":"1325_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.immuni.2018.03.019","volume":"48","author":"M Xu","year":"2018","unstructured":"Xu M, Lu H, Lee YH, Wu Y, Liu K, Shi Y, et al. An interleukin-25-mediated autoregulatory circuit in keratinocytes plays a pivotal role in psoriatic skin inflammation. Immunity. 2018;48:787\u201398.e4.","journal-title":"Immunity"},{"key":"1325_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","volume":"49","author":"M Wang","year":"2018","unstructured":"Wang M, Zhang S, Zheng G, Huang J, Songyang Z, Zhao X, et al. Gain-of-function mutation of Card14 leads to spontaneous psoriasis-like skin inflammation through enhanced keratinocyte response to IL-17A. Immunity. 2018;49:66\u201379.e5.","journal-title":"Immunity"},{"key":"1325_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39020-4","volume":"14","author":"F Ma","year":"2023","unstructured":"Ma F, Plazyo O, Billi AC, Tsoi LC, Xing X, Wasikowski R, et al. Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis. Nat Commun. 2023;14:3455.","journal-title":"Nat Commun"},{"key":"1325_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.immuni.2011.12.003","volume":"35","author":"P Di Meglio","year":"2011","unstructured":"Di Meglio P, Perera GK, Nestle FO. The multitasking organ: recent insights into skin immune function. Immunity. 2011;35:857\u201369.","journal-title":"Immunity"},{"key":"1325_CR15","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1039\/D2TB00614F","volume":"10","author":"A Chen","year":"2022","unstructured":"Chen A, Luo Y, Xu J, Guan X, He H, Xuan X, et al. Latest on biomaterial-based therapies for topical treatment of psoriasis. J Mater Chem B. 2022;10:7397\u2013417.","journal-title":"J Mater Chem B"},{"key":"1325_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep06812","volume":"4","author":"W Pan","year":"2014","unstructured":"Pan W, Cheng Y, Zhang H, Liu B, Mo X, Li T, et al. CSBF\/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest. Sci Rep. 2014;4:6812.","journal-title":"Sci Rep"},{"key":"1325_CR17","doi-asserted-by":"publisher","first-page":"eaal0180","DOI":"10.1126\/scisignal.aal0180","volume":"10","author":"T Suply","year":"2017","unstructured":"Suply T, Hannedouche S, Carte N, Li J, Grosshans B, Schaefer M, et al. A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia. Sci Signal. 2017;10:eaal0180.","journal-title":"Sci Signal"},{"key":"1325_CR18","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1237013","volume":"340","author":"SV Kim","year":"2013","unstructured":"Kim SV, Xiang WV, Kwak C, Yang Y, Lin XW, Ota M, et al. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science. 2013;340:1456\u20139.","journal-title":"Science"},{"key":"1325_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3389\/fimmu.2017.01111","volume":"8","author":"B Oc\u00f3n","year":"2017","unstructured":"Oc\u00f3n B, Pan J, Dinh TT, Chen W, Ballet R, Bscheider M, et al. A mucosal and cutaneous chemokine ligand for the lymphocyte chemoattractant receptor GPR15. Front Immunol. 2017;8:1111.","journal-title":"Front Immunol"},{"key":"1325_CR20","doi-asserted-by":"publisher","first-page":"e53246","DOI":"10.15252\/embr.202153246","volume":"23","author":"J Song","year":"2022","unstructured":"Song J, Zheng H, Xue J, Liu J, Sun Q, Yang W, et al. GPR15-C10ORF99 functional pairing initiates colonic Treg homing in amniotes. EMBO Rep. 2022;23:e53246.","journal-title":"EMBO Rep"},{"key":"1325_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjae012","volume":"18","author":"S Schramm","year":"2024","unstructured":"Schramm S, Liu LJ, Saad M, Dietz L, Dedden M, M\u00fcller TM, et al. Blocking GPR15 counteracts integrin-dependent T-cell gut homing in vivo. J Crohns Colitis. 2024;18:1162\u201372.","journal-title":"J Crohns Colitis"},{"key":"1325_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jdermsci.2019.01.008","volume":"94","author":"T Sezin","year":"2019","unstructured":"Sezin T, Kempen L, Meyne LM, Mousavi S, Zillikens D, Sadik CD. GPR15 is not critically involved in the regulation of murine psoriasiform dermatitis. J Dermatol Sci. 2019;94:196\u2013204.","journal-title":"J Dermatol Sci"},{"key":"1325_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ygeno.2013.11.001","volume":"103","author":"P Guo","year":"2014","unstructured":"Guo P, Luo Y, Mai G, Zhang M, Wang G, Zhao M, et al. Gene expression profile based classification models of psoriasis. Genomics. 2014;103:48\u201355.","journal-title":"Genomics"},{"key":"1325_CR24","doi-asserted-by":"publisher","first-page":"825032","DOI":"10.3389\/fimmu.2022.825032","volume":"13","author":"T Dainichi","year":"2022","unstructured":"Dainichi T, Nakano Y, Doi H, Nakamizo S, Nakajima S, Matsumoto R, et al. C10orf99\/GPR15L regulates proinflammatory response of keratinocytes and barrier formation of the skin. Front Immunol. 2022;13:825032.","journal-title":"Front Immunol"},{"key":"1325_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ijpharm.2015.09.005","volume":"495","author":"X Li","year":"2015","unstructured":"Li X, Fan R, Tong A, Yang M, Deng J, Zhou L, et al. In situ gel-forming AP-57 peptide delivery system for cutaneous wound healing. Int J Pharm. 2015;495:560\u201371.","journal-title":"Int J Pharm"},{"key":"1325_CR26","unstructured":"Bassilana F, BB, Carte NMT, Detheux M, Falchetto R, Hannedouche S. Organic compounds. 2015. Google Patents."},{"key":"1325_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26996-z","volume":"8","author":"C Chen","year":"2018","unstructured":"Chen C, Wu N, Duan Q, Yang H, Wang X, Yang P, et al. C10orf99 contributes to the development of psoriasis by promoting the proliferation of keratinocytes. Sci Rep. 2018;8:8590.","journal-title":"Sci Rep"},{"key":"1325_CR28","doi-asserted-by":"publisher","first-page":"eabm7342","DOI":"10.1126\/sciadv.abm7342","volume":"8","author":"PY Tseng","year":"2022","unstructured":"Tseng PY, Hoon MA. GPR15L is an epithelial inflammation-derived pruritogen. Sci Adv. 2022;8:eabm7342.","journal-title":"Sci Adv"},{"key":"1325_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.immuni.2020.09.015","volume":"53","author":"TK Hughes","year":"2020","unstructured":"Hughes TK, Wadsworth MH, Gierahn TM, Do T, Weiss D, Andrade PR, et al. Second-strand synthesis-based massively parallel scRNA-seq reveals cellular states and molecular features of human inflammatory skin pathologies. Immunity. 2020;53:878\u201394.e7.","journal-title":"Immunity"},{"key":"1325_CR30","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1016\/j.jid.2022.04.014","volume":"142","author":"J Wang","year":"2022","unstructured":"Wang J, Li X, Zhang P, Yang T, Liu N, Qin L, et al. CHRNA5 is overexpressed in patients with psoriasis and promotes psoriasis-like inflammation in mouse models. J Investig Dermatol. 2022;142:2978\u201387.e6.","journal-title":"J Investig Dermatol"},{"key":"1325_CR31","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.1301737","volume":"192","author":"CB Russell","year":"2014","unstructured":"Russell CB, Rand H, Bigler J, Kerkof K, Timour M, Bautista E, et al. Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol. 2014;192:3828\u201336.","journal-title":"J Immunol"},{"key":"1325_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity. 2019;50:892\u2013906.","journal-title":"Immunity"},{"key":"1325_CR33","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.20071978","volume":"205","author":"XO Yang","year":"2008","unstructured":"Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, et al. Regulation of inflammatory responses by IL-17F. J Exp Med. 2008;205:1063\u201375.","journal-title":"J Exp Med"},{"key":"1325_CR34","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3389\/fimmu.2020.01858","volume":"11","author":"L Jegodzinski","year":"2020","unstructured":"Jegodzinski L, Sezin T, Loser K, Mousavi S, Zillikens D, Sadik CD. The G protein-coupled receptor (GPR) 15 counteracts antibody-mediated skin inflammation. Front Immunol. 2020;11:1858.","journal-title":"Front Immunol"},{"key":"1325_CR35","doi-asserted-by":"publisher","first-page":"e104202","DOI":"10.15252\/embj.2019104202","volume":"39","author":"H Draberova","year":"2020","unstructured":"Draberova H, Janusova S, Knizkova D, Semberova T, Pribikova M, Ujevic A, et al. Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loop. EMBO J. 2020;39:e104202.","journal-title":"EMBO J"},{"key":"1325_CR36","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1073\/pnas.160265197","volume":"97","author":"X Li","year":"2000","unstructured":"Li X, Commane M, Nie H, Hua X, Chatterjee-Kishore M, Wald D, et al. Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci USA. 2000;97:10489\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1325_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/ni.2093","volume":"12","author":"MJ May","year":"2011","unstructured":"May MJ. IL-17R signaling: new players get in on the Act1. Nat Immunol. 2011;12:813\u20135.","journal-title":"Nat Immunol"},{"key":"1325_CR38","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.immuni.2023.06.012","volume":"56","author":"Q Luo","year":"2023","unstructured":"Luo Q, Liu Y, Shi K, Shen X, Yang Y, Liang X, et al. An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression. Immunity. 2023;56:2006\u20132020.e6.","journal-title":"Immunity"},{"key":"1325_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ni1439","volume":"8","author":"Y Qian","year":"2007","unstructured":"Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007;8:247\u201356.","journal-title":"Nat Immunol"},{"key":"1325_CR40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1084\/jem.191.7.1233","volume":"191","author":"R Schwandner","year":"2000","unstructured":"Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med. 2000;191:1233\u201340.","journal-title":"J Exp Med"},{"key":"1325_CR41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.immuni.2004.09.001","volume":"21","author":"Y Qian","year":"2004","unstructured":"Qian Y, Qin J, Cui G, Naramura M, Snow EC, Ware CF, et al. Act1, a negative regulator in CD40- and BAFF-mediated B-cell survival. Immunity. 2004;21:575\u201387.","journal-title":"Immunity"},{"key":"1325_CR42","doi-asserted-by":"publisher","first-page":"9386","DOI":"10.1073\/pnas.142294499","volume":"99","author":"Y Qian","year":"2002","unstructured":"Qian Y, Zhao Z, Jiang Z, Li X. Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc Natl Acad Sci USA. 2002;99:9386\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1325_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4049\/jimmunol.0903312","volume":"185","author":"NV Giltiay","year":"2010","unstructured":"Giltiay NV, Lu Y, Allman D, J\u00f8rgensen TN, Li X. The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B-cell selection during transitional B-cell maturation. J Immunol. 2010;185:99\u2013109.","journal-title":"J Immunol"},{"key":"1325_CR44","doi-asserted-by":"publisher","first-page":"ra63","DOI":"10.1126\/scisignal.2000382","volume":"2","author":"C Liu","year":"2009","unstructured":"Liu C, Qian W, Qian Y, Giltiay NV, Lu Y, Swaidani S, et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal. 2009;2:ra63.","journal-title":"Sci Signal"},{"key":"1325_CR45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.immuni.2008.02.017","volume":"28","author":"YP Rubtsov","year":"2008","unstructured":"Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T-cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28:546\u201358.","journal-title":"Immunity"},{"key":"1325_CR46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50:871\u201391.","journal-title":"Immunity"},{"key":"1325_CR47","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.immuni.2023.11.003","volume":"56","author":"L Brockmann","year":"2023","unstructured":"Brockmann L, Tran A, Huang Y, Edwards M, Ronda C, Wang HH, et al. Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10. Immunity. 2023;56:2719\u201335.e7.","journal-title":"Immunity"},{"key":"1325_CR48","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41590-022-01326-8","volume":"23","author":"B Zhao","year":"2022","unstructured":"Zhao B, Gong W, Ma A, Chen J, Velegraki M, Dong H, et al. SUSD2 suppresses CD8(+) T-cell antitumor immunity by targeting IL-2 receptor signaling. Nat Immunol. 2022;23:1588\u201399.","journal-title":"Nat Immunol"},{"key":"1325_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4049\/jimmunol.2300629","volume":"213","author":"W Zhang","year":"2024","unstructured":"Zhang W, Pajulas A, Niese M, Zhou H, Zhao J, Akhtar N, et al. Diminished \u03b3\u03b4 T cells during murine allergic skin inflammation is mediated by IL-4 signaling in keratinocytes. J Immunol. 2024;213:125\u201334.","journal-title":"J Immunol"},{"key":"1325_CR50","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1016\/j.jid.2022.03.012","volume":"142","author":"J Wang","year":"2022","unstructured":"Wang J, Pajulas A, Fu Y, Adom D, Zhang W, Nelson AS, et al. \u03b3\u03b4 T-Cell\u2012mediated wound healing is diminished by allergic skin inflammation. J Invest Dermatol. 2022;142:2805\u201316.e4.","journal-title":"J Invest Dermatol"},{"key":"1325_CR51","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1084\/jem.20121871","volume":"210","author":"I Augustin","year":"2013","unstructured":"Augustin I, Gross J, Baumann D, Korn C, Kerr G, Grigoryan T, et al. Loss of epidermal Evi\/Wls results in a phenotype resembling psoriasiform dermatitis. J Exp Med. 2013;210:1761\u201377.","journal-title":"J Exp Med"},{"key":"1325_CR52","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41590-018-0071-9","volume":"19","author":"T Herjan","year":"2018","unstructured":"Herjan T, Hong L, Bubenik J, Bulek K, Qian W, Liu C, et al. IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat Immunol. 2018;19:354\u201365.","journal-title":"Nat Immunol"},{"key":"1325_CR53","doi-asserted-by":"publisher","first-page":"35603","DOI":"10.1074\/jbc.C600256200","volume":"281","author":"SH Chang","year":"2006","unstructured":"Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem. 2006;281:35603\u20137.","journal-title":"J Biol Chem"},{"key":"1325_CR54","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1126\/science.1071924","volume":"296","author":"G Chen","year":"2002","unstructured":"Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science. 2002;296:1634\u20135.","journal-title":"Science"},{"key":"1325_CR55","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)80391-X","volume":"7","author":"WC Yeh","year":"1997","unstructured":"Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, et al. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 1997;7:715\u201325.","journal-title":"Immunity"},{"key":"1325_CR56","doi-asserted-by":"publisher","first-page":"36530","DOI":"10.1074\/jbc.M104837200","volume":"276","author":"K Tada","year":"2001","unstructured":"Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S, et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem. 2001;276:36530\u20134.","journal-title":"J Biol Chem"},{"key":"1325_CR57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0014-5793(02)03688-8","volume":"532","author":"M Kanamori","year":"2002","unstructured":"Kanamori M, Kai C, Hayashizaki Y, Suzuki H. NF-kappaB activator Act1 associates with IL-1\/Toll pathway adaptor molecule TRAF6. FEBS Lett. 2002;532:241\u20136.","journal-title":"FEBS Lett"},{"key":"1325_CR58","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom Proteom Bioinform. 2021;19:578\u201383.","journal-title":"Genom Proteom Bioinform"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01325-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:58:33Z","timestamp":1757383113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01325-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":58,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01325-3","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}